Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant

被引:11
|
作者
Flisiak, Robert [1 ]
Zarebska-Michaluk, Dorota [2 ]
Dobrowolska, Krystyna [3 ]
Rorat, Marta [4 ,5 ]
Rogalska, Magdalena [1 ]
Krynska, Justyna Anna [1 ]
Moniuszko-Malinowska, Anna [6 ]
Czupryna, Piotr [6 ]
Kozielewicz, Dorota [7 ]
Jaroszewicz, Jerzy [8 ]
Sikorska, Katarzyna [9 ]
Bednarska, Agnieszka [10 ]
Piekarska, Anna [11 ]
Rzymski, Piotr [12 ]
机构
[1] Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland
[2] Jan Kochanowski Univ, Dept Infect Dis & Allergol, PL-25317 Kielce, Poland
[3] Jan Kochanowski Univ, Coll Medicum, PL-25317 Kielce, Poland
[4] Wroclaw Med Univ, Dept Infect Dis & Hepatol, PL-51149 Wroclaw, Poland
[5] Wroclaw Med Univ, Dept Forens Med, PL-50367 Wroclaw, Poland
[6] Med Univ Bialystok, Dept Infect Dis & Neuroinfect, PL-15809 Bialystok, Poland
[7] Nicolaus Copernicus Univ, Fac Med, Dept Infect Dis & Hepatol, Coll Medicum Bydgoszcz, PL-87100 Torun, Poland
[8] Med Univ Silesia, Dept Infect Dis & Hepatol, PL-41902 Bytom, Poland
[9] Med Univ Gdansk, Fac Hlth Sci, Div Trop & Parasit Dis, PL-80210 Gdansk, Poland
[10] Med Univ Warsaw, Dept Adults Infect Dis, Hosp Infect Dis, PL-02091 Warsaw, Poland
[11] Med Univ Lodz, Dept Infect Dis & Hepatol, PL-90419 Lodz, Poland
[12] Poznan Univ Med Sci, Dept Environm Med, PL-60806 Poznan, Poland
关键词
SARS-CoV-2; COVID-19; Omicron; mortality; severity; INFECTION RECOMMENDATIONS; POLISH ASSOCIATION; EPIDEMIOLOGISTS; MANAGEMENT; OUTCOMES; WAVES;
D O I
10.3390/jcm12175572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to compare the clinical picture of COVID-19 in the initial and later period of Omicron dominance and to identify populations still at risk. A retrospective comparison of the clinical data of 965 patients hospitalized during the early period of Omicron's dominance (EO, January-June 2022) with 897 patients from a later period (LO, July 2022-April 2023) from the SARSTer database was performed. Patients hospitalized during LO, compared to EO, were older, had a better clinical condition on admission, had a lower need for oxygen and mechanical ventilation, had less frequent lung involvement in imaging, and showed much faster clinical improvement. Moreover, the overall mortality during EO was 14%, higher than that in LO-9%. Despite the milder course of the disease, mortality exceeding 15% was similar in both groups among patients with lung involvement. The accumulation of risk factors such as an age of 60+, comorbidities, lung involvement, and oxygen saturation <90% resulted in a constant need for oxygen in 98% of patients, an 8% risk of mechanical ventilation, and a 30% mortality rate in the LO period. Multiple logistic regression revealed lower odds of death during the LO phase. Despite the milder course of infections caused by the currently dominant subvariants, COVID-19 prophylaxis is necessary in people over 60 years of age, especially those with comorbidities, and in the case of pneumonia and respiratory failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
    Abas, Abdul Hawil
    Marfuah, Siti
    Idroes, Rinaldi
    Kusumawaty, Diah
    Fatimawali
    Park, Moon Nyeo
    Siyadatpanah, Abolghasem
    Alhumaydhi, Fahad A.
    Mahmud, Shafi
    Tallei, Trina Ekawati
    Bin Emran, Talha
    Kim, Bonglee
    MOLECULES, 2022, 27 (07):
  • [12] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [13] Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant
    Ullrich, Fabian
    Hanoun, Christine
    Turki, Amin T.
    Liebregts, Tobias
    Breuckmann, Katharina
    Alashkar, Ferras
    Reinhardt, Hans Christian
    von Tresckow, Bastian
    von Tresckow, Julia
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (04) : 364 - 372
  • [14] Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
    Karageorgou, Vagia
    Papaioannou, Andriana I.
    Kallieri, Maria
    Blizou, Myrto
    Lampadakis, Stefanos
    Sfika, Maria
    Krouskos, Antonios
    Papavasileiou, Vasileios
    Strakosha, Franceska
    Vandorou, Kalliopi Theoni
    Siozos, Pavlos
    Christodoulou, Marina Moustaka
    Kontonasiou, Georgia
    Apollonatou, Vasiliki
    Antonogiannaki, Elvira Markella
    Kyriakopoulos, Christos
    Aggelopoulou, Christina
    Chronis, Christos
    Kostikas, Konstantinos
    Koukaki, Evangelia
    Sotiropoulou, Zoi
    Athanasopoulou, Athanasia
    Bakakos, Petros
    Schoini, Pinelopi
    Alevrakis, Emmanouil
    Poupos, Sotirios
    Chondrou, Evangelia
    Tsoukalas, Dionisios
    Chronaiou, Alexia
    Tsoukalas, George
    Koukidou, Sofia
    Hillas, Georgios
    Dimakou, Katerina
    Roukas, Konstantinos
    Nakou, Ifigeneia
    Chloros, Diamantis
    Fouka, Evangelia
    Papiris, Spyros A.
    Loukides, Stelios
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [15] Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Wu, Can-rong
    Yin, Wan-chao
    Jiang, Yi
    Xu, H. Eric
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (12) : 3021 - 3033
  • [16] Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
    Gunadi
    Hakim, Mohamad Saifudin
    Wibawa, Hendra
    Vujira, Khanza Adzkia
    Puspitarani, Dyah Ayu
    Supriyati, Endah
    Trisnawati, Ika
    Iskandar, Kristy
    El Khair, Riat
    Afiahayati
    Siswanto
    Puspadewi, Yunika
    Irianingsih, Sri Handayani
    Nugrahaningsih, Dwi Aris Agung
    Eryvinka, Laudria Stella
    Utami, Fadila Dyah Trie
    Devana, Edita Mayda
    Aditama, Lanang
    Kinasih, Nathania Christi Putri
    Hediningsih, Yekti
    Ananda, Nur Rahmi
    Arguni, Eggi
    Nuryastuti, Titik
    Wibawa, Tri
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [17] Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
    Flisiak, Robert
    Zarebska-Michaluk, Dorota
    Rogalska, Magdalena
    Krynska, Justyna Anna
    Kowalska, Justyna
    Dutkiewicz, Ewa
    Dobrowolska, Krystyna
    Jaroszewicz, Jerzy
    Moniuszko-Malinowska, Anna
    Rorat, Marta
    Podlasin, Regina
    Tronina, Olga
    Rzymski, Piotr
    PHARMACOLOGICAL REPORTS, 2022, 74 (06) : 1279 - 1285
  • [18] COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
    Zarebska-Michaluk, Dorota
    Hu, Chenlin
    Brzdek, Michal
    Flisiak, Robert
    Rzymski, Piotr
    VACCINES, 2022, 10 (08)
  • [19] Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Can-rong Wu
    Wan-chao Yin
    Yi Jiang
    H. Eric Xu
    Acta Pharmacologica Sinica, 2022, 43 : 3021 - 3033
  • [20] Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway
    STALCRANTZ, J. E. A. N. E. T. T. E.
    KRISTOFFERSEN, A. N. J. A. B. R. A. T. H. E. N.
    BOAS, H. A. K. O. N.
    VENETI, L. A. M. P. R. I. N. I.
    SEPPALA, E. L. I. N. A.
    AASAND, N. I. N. A.
    HUNGNES, O. L. A., V
    KVALE, R. E. I. D. A. R.
    BRAGSTAD, K. A. R. O. L. I. N. E.
    BUANES, E. I. R. I. K. A. L. N. E. S.
    WHITTAKER, R. O. B. E. R. T.
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2022, 50 (06) : 676 - 682